Clinical Trials Directory

Trials / Completed

CompletedNCT00514410

Folate Augmentation of Treatment - Evaluation for Depression: a Randomised Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
730 (estimated)
Sponsor
Bangor University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To determine whether giving folic acid to people with depression will help their antidepressants work better. If folate does help antidepressants to work better, then it will provide a safe, simple and cheap way of improving the treatment of depression.

Detailed description

Clinical depression is common, debilitating and treatable; one in four people experience it during their lives. The majority of sufferers are treated in primary care and only half respond well to active treatment. Evidence suggests that folate may be a useful adjunct to antidepressant treatment: 1) patients with depression often have a functional folate deficiency; 2) the severity of such deficiency, indicated by elevated homocysteine, correlates with depression severity, 3) low folate is associated with poor antidepressant response, and 4) folate is required for the synthesis of neurotransmitters implicated in the pathogenesis and treatment of depression. The primary objective of this multi-centred placebo-controlled randomised trial is to estimate the effect of folate augmentation in new or continuing treatment of depressive disorder in primary and secondary care. Secondary objectives are to evaluate the cost-effectiveness of folate augmentation of antidepressant treatment, investigate how the response to antidepressant treatment depends on genetic polymorphisms relevant to folate metabolism and antidepressant response, and explore whether baseline folate status can predict response to antidepressant treatment. Comparisons: Eligible patients with moderate to severe depression will be randomised to receive 5mg of folic acid or placebo as an adjunct to their antidepressant treatment.

Conditions

Interventions

TypeNameDescription
DRUGFolic AcidFolic acid 5 mg once a day for three months as a supplement to their antidepressant treatment
DRUGPlaceboMatching placebo taken once a day for three months

Timeline

Start date
2007-07-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2007-08-10
Last updated
2011-10-12

Locations

3 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00514410. Inclusion in this directory is not an endorsement.